Search Results 1431-1440 of 16587 for Valproate

  1. Androgen Deprivation To Enrich PSMA Expression And Improve Sensitivity Of Staging PSMA PET/C - Mayo Clinic

    The purpose of this study is for the comparison of SUVmax and SUVmean values of the dominate primary prostate lesion between pre and post ADT imaging using ...

  2. Bone Marrow Transplant Program - Doctors - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.

  3. Publications - Pavel N. Pichurin, M.D. - Mayo Clinic

    Pinto E Vairo F, Prochnow C, Kemppainen JL, Lisi EC, Steyermark JM, Kruisselbrink TM, Pichurin PN, Dhamija R, Hager MM, Albadri S, Cornell LD, Lazaridis KN, ...

  4. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

  5. Deep vein thrombosis (DVT) - Doctors and departments - Mayo Clinic

    This potentially serious condition can occur with few or no symptoms. Know the risk factors.

  6. Clinical trials - Urology

    Urology — Learn about innovative diagnosis and treatment options for urologic diseases, including cancers, at Mayo Clinic.

  7. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

  8. Belimumab With Rituximab for Primary Membranous Nephropathy (REBOOT) - Mayo Clinic

    The primary objective of this study is to determine the effectiveness of belimumab with rituximab at inducing a complete or partial remission (CR or PR) ...

  9. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

  10. Clinical trials - Oncology (Medical)

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...